Dr Graeme Blackman AO, PhD, BSc (Hons), BD, MTheol, FTSE, FRACI, FAICD, FIoD (Chairman)
Independent Non-Executive Director and Chairman of the Company, appointed 17 August 2011, and Member of the Finance, Audit and Risk Management Committee.
Dr Blackman is a former Professor of Pharmaceutical Chemistry at the Victorian College of Pharmacy and a former director of IDT Australia Ltd, an Australian Securities Exchange (ASX) listed public company operating in the pharmaceutical industry. He was a director of the Australian Stem Cell Centre.
He has been a member of various Commonwealth and State advisory committees and working groups in pharmaceuticals and biotechnology, including the Australian Biotechnology Advisory Council, the Pharmaceutical Industry Working Group and the Pharmaceutical Industry Strategy Group. He chaired the Australian Government’s Pharmaceuticals Industry Action Agenda, which developed a policy framework for the industry over a ten year period.